{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:21:05Z","timestamp":1778599265610,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143206","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T18:42:11Z","timestamp":1449859331000},"page":"e0143206","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts"],"prefix":"10.1371","volume":"10","author":[{"given":"Minna","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"issue":"16","key":"ref1","first-page":"1547","article-title":"Multiple myeloma","volume":"20","author":"S Oftedal","year":"1921","journal-title":"Journal of the American Medical Association"},{"issue":"24","key":"ref2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma","volume":"352","author":"PG Richardson","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa070594","article-title":"Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma","volume":"357","author":"D Meletios","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2141.2005.05540.x","article-title":"Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma","volume":"129","author":"J Sundar","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"R Bataille","year":"1991","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-04-019778","article-title":"Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: Results of a multicenter phase 1\/2 study","volume":"108","author":"M Mar\u00eda-Victoria","year":"2006","journal-title":"Blood"},{"issue":"26","key":"ref7","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma","volume":"349","author":"E Tian","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"ref8","first-page":"1025","article-title":"Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice","volume":"7","author":"Z Yong-Zhan","year":"2009","journal-title":"Acta Pharmacologica Sinica"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/ijc.22033","article-title":"Serum concentrations of Dickkopf\u20101 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation","volume":"119","author":"MC Politou","year":"2006","journal-title":"International Journal of Cancer"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma","volume":"15","author":"XG Zhang","year":"1994","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"T Hideshima","year":"2007","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/jama.1969.03160090040009","article-title":"Treatment for Multiple Myeloma: Combination Chemotherapy With Different Melphalan Dose Regimens","volume":"208","author":"R Alexanian","year":"1969","journal-title":"Jama"},{"issue":"17","key":"ref13","first-page":"3877","article-title":"Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells","volume":"53","author":"PA Moalli","year":"1993","journal-title":"Cancer Research"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"M Fulciniti","year":"2009","journal-title":"Blood"},{"issue":"33","key":"ref15","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.1016\/j.biomaterials.2012.07.041","article-title":"Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway","volume":"33","author":"S Xiaoqiang","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12185-009-0340-3","article-title":"Enediynelidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase","volume":"90","author":"YZ Zhen","year":"2009","journal-title":"International Journal of Hematology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.V79.1.213.213","article-title":"A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA","volume":"79","author":"PA Moalli","year":"1992","journal-title":"Blood"},{"issue":"1","key":"ref18","first-page":"52","article-title":"Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma","volume":"20","author":"X Filella","year":"1996","journal-title":"Cancer Detection & Prevention"},{"issue":"10","key":"ref19","first-page":"1277","article-title":"Bovine lactoferrin improves bone mass and micro-structure in ovariectomized rats via OPG\/RANKL\/RANK pathway","volume":"33","author":"H Jian-Ming","year":"2012","journal-title":"ActaPharmacologicaSinica"},{"issue":"6937","key":"ref20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"T Hiroshi","year":"2003","journal-title":"Nature"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1083\/jcb.98.4.1247","article-title":"Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopuslaevis oocytes and eggs","volume":"98","author":"J Gerhart","year":"1984","journal-title":"Journal of Cell Biology"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"SC Manolagas","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bone.2012.09.029","article-title":"Wnt\/\u03b2-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts","volume":"52","author":"Z Rongrong","year":"2013","journal-title":"Bone"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1158\/1078-0432.CCR-03-0366","article-title":"Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-\u03baB p65 subunit","volume":"10","author":"J Guo","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nrc952","article-title":"Molecular mechanisms of novel therapeutic approaches for multiple myeloma","volume":"2","author":"T Hideshima","year":"2002","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood.V75.3.715.715","article-title":"Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption","volume":"75","author":"H Ishikawa","year":"1990","journal-title":"Blood"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00774-009-0154-7","article-title":"Targeting the bone microenvironment in multiple myeloma","volume":"28","author":"GD Roodman","year":"2010","journal-title":"Journal of Bone & Mineral Metabolism"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/bimj.200410124","article-title":"Design and Analysis of Drug Combination Experiments","volume":"47","author":"R Straetemans","year":"2005","journal-title":"Biometrical Journal"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","article-title":"Systems biology and combination therapy in the quest for clinical efficacy","volume":"2","author":"JB Fitzgerald","year":"2006","journal-title":"Nature Chemical Biology"},{"issue":"339","key":"ref30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/01621459.1972.10481251","article-title":"Significance Testing of the Spearman Rank Correlation Coefficient","volume":"67","author":"JH Zar","year":"1972","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","article-title":"Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity","volume":"116","author":"S Yaccoby","year":"2002","journal-title":"British Journal of Haematology"},{"issue":"13","key":"ref32","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: pathophysiology of osteoblast inhibition","volume":"108","author":"G Nicola","year":"2006","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T14:17:03Z","timestamp":1599920223000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143206"}},"subtitle":[],"editor":[{"given":"Zhang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143206","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}